Indraprastha Medical Corp Q1 Results Total Income ₹347.86 Crore & Operating Profit ₹56.08 Crore

Indraprastha Medical Corp Q1 Results: Indraprastha Medical Corp’s financial results for Q1 June 2024 show significant improvements compared to the same quarter last year. The total income for this quarter was ₹347.86 crore, which is a 13.49% increase year-over-year (YoY). This means that this quarter’s income is 13.49% higher than it was in the same quarter of the previous year. The operating profit also saw a notable rise of 49.75% YoY, reaching ₹56.08 crore. This increase indicates that the company’s core operations were much more profitable this year compared to last year.

In terms of net income, Indraprastha Medical Corp earned ₹44.77 crore, up 46.79% YoY, showing a strong improvement in overall profitability. The operating margin, which measures the proportion of income that is profit, increased by 31.95% YoY, reaching 16.12%.

Comparing this quarter to the previous quarter (QoQ), the total income rose by 10.53%, showing growth from the last three months. The operating income increased by 46.69% QoQ, which indicates a significant improvement in earnings from operations. This quarter-on-quarter growth highlights the company's positive financial momentum over the short term. Overall, the YoY improvements across all key metrics suggest that Indraprastha Medical Corp has been performing strongly over the past year.

Here's a summary of Indraprastha Medical Corp's Q1 results for June 2024:

Source: Here 

For More Q1 Results check our Twitter Page

Visit our website for more Q1 results 

Indraprastha Medical Corp Q1 Results

Indraprastha Medical Corporation has released its financial results for the quarter ending on June 30, 2024. The company earned Rs. 347.86 crore from its operations during this quarter, which is higher than the Rs. 306.51 crore it earned in the same quarter last year. Additionally, the company made Rs. 5.12 crore from other sources, bringing the total income to Rs. 352.98 crore. This is an increase from Rs. 310.07 crore in the previous year.

Indraprastha Medical Corporation’s total expenses for this quarter were Rs. 293.39 crore. Major expenses included Rs. 58.93 crore for materials, Rs. 66.59 crore for employee salaries, and Rs. 90.67 crore for paying doctors. Other costs included Rs. 1.61 crore in finance charges and Rs. 11.04 crore for depreciation. Despite these costs, the company’s profit before tax was Rs. 59.59 crore, up from Rs. 40.23 crore a year ago.

After paying taxes, the profit for the quarter was Rs. 44.77 crore. Indraprastha Medical Corporation also reported a total comprehensive income of Rs. 46.75 crore, which includes additional income items. The value of each share remained at Rs. 10, and the earnings per share for this quarter was Rs. 4.88, showing a good financial performance for the period.

Here is a simplified summary of the unaudited financial results for Indraprastha Medical Corporation for the quarter ended June 30, 2024:

Indraprastha Medical Corp Financial Metrics

Indraprastha Medical Corp has a market value of ₹4,086 Crores, meaning that's how much the company is worth in total on the stock market. The current price of one share is ₹446. Over the past period, the share price reached a high of ₹480 and a low of ₹149. The company has a Price-to-Earnings (P/E) ratio of 29.5, showing how expensive its shares are relative to its earnings. Each share is worth ₹52.1 based on its book value. The dividend yield is 1.00%, which is the return shareholders get from dividends. 

Here's a summary of the financial data for the company:

Quarterly Results 

For Indraprastha Medical Corp, the table shows the financial performance for December 2023, March 2024, and June 2024. In December 2023, the company had sales of ₹306 crores and expenses of ₹259 crores, leading to an operating profit of ₹47 crores, which is 15% of sales. By March 2024, sales increased to ₹315 crores, expenses rose to ₹266 crores, and operating profit grew to ₹48 crores, maintaining a 15% profit margin. 

Here is the table for Dec 2023, Mar 2024, and Jun 2024:

About Indraprastha Medical Corp 

Indraprastha Medical Corporation is a company founded in 1988 through a partnership between the Government of Delhi and Apollo Hospitals Group. This partnership was created to build Indraprastha Apollo Hospitals, a large multi-specialty hospital located in Sarita Vihar, New Delhi. The hospital provides advanced medical care with a wide range of specialties, including cardiology, cancer treatment, pediatrics, and many more. The Government of Delhi owns 26% of the company, Apollo Hospitals Group owns 25%, and the remaining 49% is held by the public.

Indraprastha Medical Corporation is known for its state-of-the-art technology and has 710 beds. It is spread across 15 acres with over 600,000 square feet of space. The hospital features advanced equipment like robotic surgery systems and MRI scanners and has received multiple accreditations, including being the first hospital in India to be accredited by JCI in 2005. The focus of Indraprastha Apollo Hospitals is on providing top-quality medical care through the latest technology and highly trained staff.